De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-Infected Tissues: Implications for Primary Letermovir Resistance

In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

(2019) Jochen J Frietsch et al.   Mediterranean Journal of Hematology and Infectious Diseases

Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

(2019) Raymund R. Razonable et al.   CLINICAL TRANSPLANTATION

Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance

(2019) Jocelyne Piret et al.   ANTIVIRAL RESEARCH

Improving our Mechanistic Understanding of the Indirect Effects of CMV Infection in Transplant Recipients

(2019) Arnaud G. L'Huillier et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient

(2019) Susanne Jung et al.   BMC INFECTIOUS DISEASES

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

(2019) Per Ljungman et al.   LANCET INFECTIOUS DISEASES

Letermovir as Salvage Therapy for CMV Infection in Transplant Recipients

(2019) Pakpoom Phoompoung et al.   TRANSPLANTATION

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation

(2019) Per Ljungman et al.   CLINICAL INFECTIOUS DISEASES

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

(2019) Guy El Helou et al.   Infection and Drug Resistance

In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products

(2019) Takashi E. Komatsu et al.   ANTIVIRAL RESEARCH

Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection

(2018) Lauren Cherrier et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir

(2016) Peter Lischka et al.   ANTIVIRAL RESEARCH

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

(2016) P. Teira et al.   BLOOD

RapidIn VitroEvolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance

(2015) Sunwen Chou   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir

(2015) Thomas Goldner et al.   ANTIVIRAL RESEARCH

Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)

(2015) Peter Lischka et al.   JOURNAL OF INFECTIOUS DISEASES

Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization

(2014) H. Do et al.   CLINICAL CHEMISTRY

The pathogenesis of human cytomegalovirus

(2014) Paul Griffiths et al.   JOURNAL OF PATHOLOGY

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

(2014) Roy F. Chemaly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure

(2013) Thomas Goldner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Virologic Suppression Measured by a Cytomegalovirus (CMV) DNA Test Calibrated to the World Health Organization International Standard Is Predictive of CMV Disease Resolution in Transplant Recipients

(2013) Raymund R. Razonable et al.   CLINICAL INFECTIOUS DISEASES

Quality scores and SNP detection in sequencing-by-synthesis systems

(2008) W. Brockman et al.   GENOME RESEARCH